That resource is reserved for health professionals and professionals using DM-DIV

This content is promotional.


The mAbXmise quantification kits are intended to monitor the concentration of therapeutic monoclonal antibodies (mAbs) in samples from patients treated with these mAbs. The kit is a quantitative assay. The test can be performed on plasma (EDTA, heparin or citrate collection tubes) and serum. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product.


This space contains information on medical devices, the use of which is reserved for healthcare professionals. In application of the law of December 29, 2011 relating to the strengthening of health security, I certify that I am a health professional and therefore be authorized to access this information.


mAbXmise monoclonal antibodies quantification kits are In Vitro Diagnostic Medical Devices for laboratory professional use and CE-IVD labeled for Europe by BSI. Assay results are intended to be used by healthcare professionals. The kits are designed to perform absolute quantification by LC-MS (Liquid Chromatography – Mass spectrometry) of specific therapeutic monoclonal antibodies (mAbs) in a patient sample. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product. The products are non-refundable. The mAbXmise Kit described has not been cleared by any regulatory entity for diagnostic purposes outside of Europe. Proteomics mAbXmise Kits are not available for sale in all countries.


I am a healthcare professional


Validate


Close window if you are not a healthcare professional

 

Close menu

Contact

Technical note

We are pleased to share with you the publication of a technical note from Thermo Fisher Scientific, a giant in life science innovation!

In this exciting technical note, “Streamlined workflow for absolute quantitation of therapeutic monoclonal antibodies using Promise Proteomics mAbXmise kits and a TSQ Altis Plus mass spectrometer”, the authors aim to simultaneously quantify the signature peptides of multiple therapeutic monoclonal antibodies in human serum in a streamlined and confident way using Promise Proteomics kits and the TSQ Altis Plus mass spectrometer.

 

 

 

Highlights of this successful evaluation of the Promise Proteomics mAbXmise kits in the TSQ Altis Plus mass spectrometer for quantitative analysis of mAbs:

  • High reproducibility and accuracy
  • Sensitive and robust data with high confidence
  • Can promote laboratory productivity and efficiency by monitoring multiple mAbs in a single workflow

 

Feel free to read the full Technical Note and share your thoughts with us :

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.